176 related articles for article (PubMed ID: 38434025)
1. HIV-1 proviral DNA in purified peripheral blood CD34
Tassaneetrithep B; Phuphuakrat A; Pasomsub E; Bhukhai K; Wongkummool W; Priengprom T; Khamaikawin W; Chaisavaneeyakorn S; Anurathapan U; Apiwattanakul N; Hongeng S
Heliyon; 2024 Feb; 10(4):e26613. PubMed ID: 38434025
[TBL] [Abstract][Full Text] [Related]
2. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption.
Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173
[TBL] [Abstract][Full Text] [Related]
3. The CCR5 Gene Edited CD34
Karuppusamy KV; Demosthenes JP; Venkatesan V; Christopher AC; Babu P; Azhagiri MK; Jacob A; Ramalingam VV; Rangaraj S; Murugesan MK; Marepally SK; Varghese GM; Srivastava A; Kannangai R; Thangavel S
Front Immunol; 2022; 13():792684. PubMed ID: 35359982
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo.
Renelt S; Schult-Dietrich P; Baldauf HM; Stein S; Kann G; Bickel M; Kielland-Kaisen U; Bonig H; Marschalek R; Rieger MA; Dietrich U; Duerr R
Cells; 2022 Sep; 11(19):. PubMed ID: 36230931
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.
Otero M; Nunnari G; Leto D; Sullivan J; Wang FX; Frank I; Xu Y; Patel C; Dornadula G; Kulkosky J; Pomerantz RJ
AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1097-103. PubMed ID: 14709246
[TBL] [Abstract][Full Text] [Related]
6. Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy.
Gabuzda D; Yin J; Misra V; Chettimada S; Gelman BB
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112989
[TBL] [Abstract][Full Text] [Related]
7. Experimental Treatment of SIV-Infected Macaques via Autograft of
Yu S; Ou Y; Xiao H; Li J; Adah D; Liu S; Zhao S; Qin L; Yao Y; Chen X
Mol Ther Methods Clin Dev; 2020 Jun; 17():520-531. PubMed ID: 32258215
[TBL] [Abstract][Full Text] [Related]
8. Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA.
Simonetti FR; White JA; Tumiotto C; Ritter KD; Cai M; Gandhi RT; Deeks SG; Howell BJ; Montaner LJ; Blankson JN; Martin A; Laird GM; Siliciano RF; Mellors JW; Siliciano JD
Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18692-18700. PubMed ID: 32690683
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy.
Falcinelli SD; Kilpatrick KW; Read J; Murtagh R; Allard B; Ghofrani S; Kirchherr J; James KS; Stuelke E; Baker C; Kuruc JD; Eron JJ; Hudgens MG; Gay CL; Margolis DM; Archin NM
J Infect Dis; 2021 Jul; 224(1):92-100. PubMed ID: 33216132
[TBL] [Abstract][Full Text] [Related]
10. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
11. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant.
Salgado M; Kwon M; Gálvez C; Badiola J; Nijhuis M; Bandera A; Balsalobre P; Miralles P; Buño I; Martinez-Laperche C; Vilaplana C; Jurado M; Clotet B; Wensing A; Martinez-Picado J; Diez-Martin JL;
Ann Intern Med; 2018 Nov; 169(10):674-683. PubMed ID: 30326031
[TBL] [Abstract][Full Text] [Related]
13. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
Gibellini D; Vitone F; Schiavone P; Ponti C; La Placa M; Re MC
J Clin Virol; 2004 Apr; 29(4):282-9. PubMed ID: 15018857
[TBL] [Abstract][Full Text] [Related]
14. New Assay Reveals Vast Excess of Defective over Intact HIV-1 Transcripts in Antiretroviral Therapy-Suppressed Individuals.
Martin HA; Kadiyala GN; Telwatte S; Wedrychowski A; Chen TH; Moron-Lopez S; Arneson D; Hoh R; Deeks S; Wong J; Yukl SA
J Virol; 2022 Dec; 96(24):e0160522. PubMed ID: 36448806
[TBL] [Abstract][Full Text] [Related]
15. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy.
Gálvez C; Grau-Expósito J; Urrea V; Clotet B; Falcó V; Buzón MJ; Martinez-Picado J
mBio; 2021 Dec; 12(6):e0307821. PubMed ID: 34844430
[TBL] [Abstract][Full Text] [Related]
16. The gut mucosal viral reservoir in HIV-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapy.
Lerner P; Guadalupe M; Donovan R; Hung J; Flamm J; Prindiville T; Sankaran-Walters S; Syvanen M; Wong JK; George MD; Dandekar S
J Virol; 2011 May; 85(10):4772-82. PubMed ID: 21345945
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Active HIV-1 Infection in CD34
Latinovic OS; Neal LM; Tagaya Y; Heredia A; Medina-Moreno S; Zapata JC; Reitz M; Bryant J; Redfield RR
AIDS Res Hum Retroviruses; 2019 Aug; 35(8):718-728. PubMed ID: 31099257
[TBL] [Abstract][Full Text] [Related]
18. Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy.
Papasavvas E; Azzoni L; Ross BN; Fair M; Yuan Z; Gyampoh K; Mackiewicz A; Sciorillo AC; Pagliuzza A; Lada SM; Wu G; Goh SL; Bahnck-Teets C; Holder DJ; Zuck PD; Damra M; Lynn KM; Tebas P; Mounzer K; Kostman JR; Abdel-Mohsen M; Richman D; Chomont N; Howell BJ; Montaner LJ
Clin Infect Dis; 2021 Feb; 72(3):495-498. PubMed ID: 33527127
[TBL] [Abstract][Full Text] [Related]
19. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.
Omondi FH; Sudderuddin H; Shahid A; Kinloch NN; Jones BR; Miller RL; Tsai O; MacMillan D; Trocha A; Brockman MA; Brumme CJ; Joy JB; Liang R; Walker BD; Brumme ZL
mBio; 2021 Dec; 12(6):e0249021. PubMed ID: 34781741
[TBL] [Abstract][Full Text] [Related]
20. Discordance between HIV-1 Population in Plasma at Rebound after Structured Treatment Interruption and Archived Provirus Population in Peripheral Blood Mononuclear Cells.
Hendricks CM; Cash MN; Tagliamonte MS; Riva A; Brander C; Llano A; Salemi M; Stevenson M; Mavian C
Microbiol Spectr; 2022 Aug; 10(4):e0135322. PubMed ID: 35699458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
